亚临床甲减的治疗阈值:TSH 4-10 mIU/L是否需要干预?

ISSN:2705-098X(P)

EISSN:2705-0505(O)

语言:中文

作者
郭辰璇,刘春燕
文章摘要

亚临床甲减(SCH)以血清促甲状腺激素(TSH)水平升高、游离甲状腺素(FT4)水平正常为特征,TSH处于4-10 mIU/L时是否干预尚无定论。本综述系统梳理该阈值区间的病理生理机制、临床风险、治疗效果及争议,结合最新循证医学证据,探讨个体化治疗策略,为明确亚临床甲减治疗阈值提供理论依据。

文章关键词
亚临床甲减;促甲状腺激素;治疗阈值
参考文献

[1] Helfand M,Crapo LM,Curry SJ,et al.Screening for Subclinical Hypothyroidism in Adults:US Preventive Services Task Force Recommendation Statement[J].JAMA,2021,325(20):2065-2073.
[2] Cooper DS.Subclinical Hypothyroidism[J].N Engl J Med,2001,345(6):406-415.
[3] Surks MI,Ortiz E,Daniels GH,et al.Subclinical thyroid disease:scientific review and guidelines for diagnosis and management[J]. JAMA,2004,291(11):1346-1355.
[4] Biondi B,Cooper DS.The clinical significance of subclinical hypothyroidism[J].N Engl J Med,2019,381(5):450-458.
[5] Negro R,Aveni P,Fiore D,et al.Long-term normalization of serum TSH in subclinical hypothyroidism is associated with a reduction in total and LDL cholesterol levels[J].J Clin Endocrinol Metab,2007,92(9):3372-3379.
[6] Arem H,Brabant G.Clinical review:Thyroid function and insulin resistance[J].J Clin Endocrinol Metab,2010,95(7):3139-3150.
[7] Gencer B,Murat-Kilic A,Collet TH,et al.Subclinical hypothyroidism and risk of coronary heart disease and heart failure:a meta- analysis[J].JAMA Intern Med,2014,174(5):816-825.
[8] Klein I,Ojamaa K.Thyroid hormone and the cardiovascular system[J].N Engl J Med,2001,344(7):501-509.
[9] Rodondi N,Auer J,Galli L,et al.Subclinical hypothyroidism and the risk of coronary heart disease and death[J].JAMA,2010,304(1):49-59.
[10] Weng S,Li J,Xu Y,et al.Association between subclinical hypothyroidism and cognitive function:a systematic review and meta- analysis[J].Eur J Endocrinol,2018,178(3):183-193.
[11] de Carvalho DP,Nobrega JT,de Carvalho GA.Thyroid function and the brain[J].Arq Neuropsiquiatr,2013,71(10):773-780.
[12] Negro R,Schwartz A,Gismondi R,et al.Effect of levothyroxine treatment in pregnancy on fetal neuropsychological development[J].N Engl J Med,2017,376(1):81-91.
[13] Casey BM,Dashe JS,Wells CE,et al.Subclinical hypothyroidism and pregnancy outcomes[J].Obstet Gynecol,2005,105(2):239-245.
[14] Razvi S,Weaver JU,Vanderpump MP,et al.Levothyroxine treatment in patients with subclinical hypothyroidism:a randomized, placebo- controlled trial[J].Ann Intern Med,2012,156(12):805-814.
[15] Negro R,Aveni P,Fiore D,et al.Long-term normalization of serum TSH in subclinical hypothyroidism is associated with a reduction in total and LDL cholesterol levels[J].J Clin Endocrinol Metab,2007,92(9):3372-3379.
[16] Jonklaas J,Bianco AC,Bauer AJ,et al.Guidelines for the treatment of hypothyroidism:prepared by the American Thyroid Association Task Force on Hypothyroidism[J].Thyroid,2014,24(12):1670-1751.
[17] Ross DS,Burch HB,Cooper DS,et al.2017 American Thyroid Association guidelines for the diagnosis and management of thyroid disease during pregnancy and the postpartum[J].Thyroid,2017,27(3):315-389.
[18] Leese GP,Park CM,Sheppard MC,et al.A randomized controlled trial of thyroxine treatment of mild(sub-clinical)hypothyroidism[J]. Clin Endocrinol(Oxf),2006,65(5):593-599.
[19] Biondi B,Palmieri EA,Fazio S,et al.Effects of L-thyroxine replacement on cardiovascular risk factors in patients with subclinical hypothyroidism:a randomized,placebo-controlled trial[J].JAMA,2007,297(16):1931-1939.
[20] Collet TH,Denke MA,Daniels GH,et al.Subclinical hypothyroidism:a review of the literature and recommendations for clinical practice[J].Ann Intern Med,2014,160(11):750-758.
[21] 中华医学会内分泌学分会.中国甲状腺疾病诊治指南(2023版)[J].中华内分泌代谢杂志,2023,39(8):651-707.
[22] Garber JR,Cobin RH,Gharib H,et al.Clinical practice guidelines for hypothyroidism in adults:co-sponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association[J].Thyroid,2012,22(12):1200-1235.

Full Text:
DOI